![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/ADVENZYMES.png)
Share the post "Advanced Enzyme Technologies ‘s Q2 Update: Revenue Decreases by 7.44% Year-on-Year"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -7.44 % over the year, decrease in net sales/revenue by -5.45 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 57.8 %. Marginal increase in other income during this quarter, up by 37.54%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Advanced Enzyme Technologies Limited. Profit dropped by -5.12 % Year to Year, Advanced Enzyme Technologies Limited’s profitability dropped by -4.53 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -4.55 % Year to Year. EPS decreased by -3.61 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 157.842 Cr | Rs. 154.524 Cr | Rs. 146.095 Cr | -5.45 % | -7.44 % |
| Expenses | Rs. 106.53 Cr | Rs. 103.36 Cr | Rs. 103.68 Cr | + 0.31 % | -2.68 % |
| Operating Profit | Rs. 51.31 Cr | Rs. 51.16 Cr | Rs. 42.42 Cr | -17.08 % | -17.33 % |
| OPM % | 32.51 % | 33.11 % | 29.04 % | -4.07 % | -3.47 % |
| Other Income | Rs. 6.095 Cr | Rs. 6.993 Cr | Rs. 9.618 Cr | + 37.54 % | + 57.8 % |
| Interest | Rs. 0.75 Cr | Rs. 0.87 Cr | Rs. 0.93 Cr | + 6.9 % | + 24 % |
| Depreciation | Rs. 8.73 Cr | Rs. 8.61 Cr | Rs. 8.9 Cr | + 3.37 % | + 1.95 % |
| Profit before tax | Rs. 47.93 Cr | Rs. 48.67 Cr | Rs. 42.21 Cr | -13.27 % | -11.93 % |
| Tax % | 26.56 % | 28.14 % | 20.89 % | -7.25 % | -5.67 % |
| Net Profit | Rs. 35.2 Cr | Rs. 34.98 Cr | Rs. 33.39 Cr | -4.55 % | -5.14 % |
| EPS in Rs | Rs. 3.08 | Rs. 3.05 | Rs. 2.93 | -3.93 % | -4.87 % |
Today, we’re looking at Advanced Enzyme Technologies Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a significant year-over-year sales decline of -7.44 %. However, it did see a marginal slip of -5.45 % from the previous quarter. Expenses ticked up slightly by 0.31 % quarter-on-quarter, aligning with the annual decline of -2.68 %. Operating profit, while down -17.33 % compared to last year, faced a quarter-on-quarter dip of -17.08 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -3.47 %, but a shrinkage of -4.07 % sequentially. Other income rose by 37.54 % compared to the last quarter, despite an annual growth of 57.8 %. Interest expenses surged remarkably by 6.9 % from the previous quarter, yet the year-over-year increase remains at a moderate 24 %. Depreciation costs climbed by 3.37 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 1.95 %. Profit before tax declined annually by -11.93 % but saw a reduction from the preceding quarter by -13.27 %.
Tax expenses as a percentage of profits decreased slightly by -5.67 % compared to last year, with a more notable quarter-on-quarter decrease of -7.25 %. Net profit fell by -5.14 % year-on-year but witnessed a -4.55 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -4.87 % but a quarterly fall of -3.93 %. In summary, Advanced Enzyme Technologies Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 157.842 Cr | Rs. 154.524 Cr | Rs. 146.095 Cr | -5.45 % | -7.44 % |
| Expenses | Rs. 106.53 Cr | Rs. 103.36 Cr | Rs. 103.68 Cr | + 0.31 % | -2.68 % |
| Operating Profit | Rs. 51.31 Cr | Rs. 51.16 Cr | Rs. 42.42 Cr | -17.08 % | -17.33 % |
| Net Profit | Rs. 35.2 Cr | Rs. 34.98 Cr | Rs. 33.39 Cr | -4.55 % | -5.14 % |
| EPS in Rs | Rs. 3.08 | Rs. 3.05 | Rs. 2.93 | -3.93 % | -4.87 % |
In reviewing Advanced Enzyme Technologies Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -7.44 % year-on-year, although there was a slight dip of -5.45 % from the previous quarter. Expenses decreased by -2.68 % compared to the previous year, with a 0.31 % increase quarter-on-quarter. Operating Profit dropped by -17.33 % annually, and saw a -17.08 % decrease from the last quarter.
Net Profit showed yearly decrease of -5.14 %, and experienced a -4.55 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -4.87 % annually, however dipped by -3.93 % compared to the last quarter. In essence, while Advanced Enzyme Technologies Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”Advanced Enzyme Technologies Limited”]
